Implantable Cardioverter Defibrillators (ICD)s are battery-powered devices placed under the skin for keeping a track of heart rate. It has been proved quite useful in preventing sudden death in patients suffering from sustained ventricular tachycardia or fibrillation. ICD holds a critical role in preventing cardiac arrest in high-risk patients who are more prone to life-threatening ventricular arrhythmias. In this process, ICD is connected through thin wires with the patient’s heart.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/implantable-cardioverter-defibrillators-market
The device delivers an electric shock to restore a normal heartbeat in case of an abnormal heart rhythm, if patient’s heart is beating chaotically and much too fast. Though ICDs have demonstrated clear life-saving benefits; concerns about patient acceptance along with psychological adjustment to the ICD have been the focus of much research.
A Full Report of Implantable Cardioverter Defibrillators Marketis Available at:https://www.omrglobal.com/industry-reports/implantable-cardioverter-defibrillators-market
As per researchers, the Quality of Life (QoL) of ICD patients can be better than that of those taking anti-arrhythmic medications. Usually, ICDs are composed of an ICD generator and wires; the first component consists of a programmable software, computer chip or circuitry with RAM (memory), a capacitor and a battery. There are two type of ICDS namely, Transvenous (TV) patients are vulnerable to complications such as fractures, which can turn to inappropriate therapy and infections.
Subcutaneous ICD is alternative novel technology used to limit complications associated with transvenous implantable cardioverter-defibrillator. Traditionally, S-ICD was used in patients with difficult venous access. As a result, congenital heart disease patients with venous anomalies are considered good candidates for S-ICD. Additionally, patients who are expected to outlive the life expectancy of their TV leads and requiring device extractions later in life can be ideal for S-ICD. It may also be used in patients with channelopathies or those who undergo renal replacement therapies and require chronic venous access.
Market Segmentation
Global Implantable CardioverterDefibrillator Market by Product
• Transvenous Implantable CardioverterDefibrillator (T-ICDS)
• Subcutaneous Implantable CardioverterDefibrillator (S-ICDS)
Global Implantable CardioverterDefibrillator Market by End-Users
• Hospitals
• Diagnostic Centers
• Ambulatory Service
• Homecare
Company Profiles
• Abbott Laboratories, Inc.
• Biotronik SE & Co. KG
• Cintas Corp.
• Defibtech, LLC
• General Electric Co.
• Koninklijke Philips N.V.
• LivaNova PLC
• Medtronic PLC
• Nihon Kohden Corp.
• Stryker Corp.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/implantable-cardioverter-defibrillators-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404